Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-25
DOI
10.3389/fonc.2020.581130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression
- (2020) He Liu et al. CLINICAL SCIENCE
- Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
- (2020) Huiyan Luo et al. Science Translational Medicine
- Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor
- (2020) Mohammad Amin Kerachian et al. Scientific Reports
- DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition
- (2020) Francesco Mannavola et al. CLINICAL SCIENCE
- Low-Pass Whole-Genome Sequencing of Circulating Cell-Free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
- (2019) Xiaoji Chen et al. CLINICAL CANCER RESEARCH
- Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study
- (2019) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Advances in Liquid Biopsy in Precision Oncology Research
- (2019) Yoshiharu Sato et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer
- (2019) Andrea Sartore‐Bianchi et al. ONCOLOGIST
- Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
- (2019) Kaoru Onidani et al. CANCER SCIENCE
- Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis
- (2019) Francesco Mannavola et al. Journal of Translational Medicine
- Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?
- (2019) Francesco Mannavola et al. Frontiers in Oncology
- Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis
- (2019) Ben O’Leary et al. CLINICAL CHEMISTRY
- Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer
- (2019) Luis Enrique Cortés-Hernández et al. MOLECULAR ASPECTS OF MEDICINE
- LBA15_PRA phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
- (2019) K Fizazi et al. ANNALS OF ONCOLOGY
- Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer
- (2019) Stella D’Oronzo et al. Scientific Reports
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
- (2019) Francesco Mannavola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Use of Liquid Biopsy in Monitoring Colorectal Cancer Progression Shows Strong Clinical Correlation
- (2018) Qiushi Sun et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
- (2018) Ying-Chi Yang et al. BIOSCIENCE REPORTS
- Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor
- (2018) Antonio Fadda et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
- (2018) Lena Gorgannezhad et al. LAB ON A CHIP
- Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
- (2018) Davina Gale et al. PLoS One
- Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
- (2018) Marco Tucci et al. Oncotarget
- Circulating tumor DNA – Current state of play and future perspectives
- (2018) Gabriele De Rubis et al. PHARMACOLOGICAL RESEARCH
- Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
- (2018) Ying-nan Yang et al. Cancer Cell International
- A six-gene assay as a new biomarker in the blood of patients with colorectal cancer: Establishment and clinical validation
- (2018) Yong Li et al. Molecular Oncology
- Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
- (2018) Chiara Cremolini et al. JAMA Oncology
- Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
- (2017) Mathilde Postel et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Circulating tumor cells in different stages of colorectal cancer
- (2017) Petra Eliasova et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
- (2017) Alan P. Venook et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers
- (2017) Tiziana Venesio et al. PATHOBIOLOGY
- KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population
- (2017) Yi-Xin Hao et al. Oncology Letters
- Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma
- (2017) Marco Tucci et al. OncoImmunology
- Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients
- (2017) Florence Koeppel et al. PLoS One
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
- (2016) S. Garrigou et al. CLINICAL CHEMISTRY
- Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack
- (2016) Michela Bulfoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
- (2016) Seon Jeong Min et al. Oncotarget
- Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer
- (2016) Wendy Onstenk et al. Oncotarget
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
- (2015) A Rowland et al. BRITISH JOURNAL OF CANCER
- Circulating Tumor Cell Enumeration in a Phase II Trial of a Four-Drug Regimen in Advanced Colorectal Cancer
- (2015) Matthew G. Krebs et al. Clinical Colorectal Cancer
- Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis
- (2015) Filippo Pietrantonio et al. EUROPEAN JOURNAL OF CANCER
- Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory,RAS-BRAFwild-type colorectal cancer receiving cetuximab or panitumumab
- (2015) Valeria Musella et al. INTERNATIONAL JOURNAL OF CANCER
- Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients
- (2015) Giulia Siravegna et al. Molecular Oncology
- The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets
- (2015) Enzo Medico et al. Nature Communications
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial
- (2014) F. Ciardiello et al. ANNALS OF ONCOLOGY
- PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
- (2014) Lee S. Schwartzberg et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- Acquired resistance to EGFR-targeted therapies in colorectal cancer
- (2014) Beth O. Van Emburgh et al. Molecular Oncology
- Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
- (2014) S. Misale et al. Cancer Discovery
- Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer
- (2013) Jean-Pierre Roperch et al. BMC CANCER
- Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
- (2013) D J E Peeters et al. BRITISH JOURNAL OF CANCER
- KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer
- (2013) K G Spindler et al. BRITISH JOURNAL OF CANCER
- Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
- (2013) Francesco Fabbri et al. CANCER LETTERS
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
- (2012) Tobias M Gorges et al. BMC CANCER
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
- (2012) K. C. A. Chan et al. CLINICAL CHEMISTRY
- Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient
- (2012) Kevin G. Phillips et al. Frontiers in Oncology
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
- (2009) J. Tol et al. ANNALS OF ONCOLOGY
- Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer
- (2009) Andrea Sartore-Bianchi et al. PLoS One
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer
- (2008) Steven J. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More